TY - JOUR AU - Ferreira, C. R. AU - Altassan, R. AU - Marques-Da-Silva, D. AU - Francisco, R. AU - Jaeken, J. AU - Morava, E. PY - 2018 DA - 2018// TI - Recognizable phenotypes in CDG JO - J Inherit Metab Dis VL - 41 UR - https://doi.org/10.1007/s10545-018-0156-5 DO - 10.1007/s10545-018-0156-5 ID - Ferreira2018 ER - TY - STD TI - Witters P, Honzik T, Bauchart E, Altassan R, Pascreau T, Bruneel A, et al. Long-term follow-up in PMM2-CDG: are we ready to start treatment trials? Genet Med. 2018 ID - ref2 ER - TY - JOUR AU - Altassan, R. AU - Péanne, R. AU - Jaeken, J. AU - Barone, R. AU - Bidet, M. AU - Borgel, D. PY - 2019 DA - 2019// TI - International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up JO - J Inherit Metab Dis VL - 42 UR - https://doi.org/10.1002/jimd.12024 DO - 10.1002/jimd.12024 ID - Altassan2019 ER - TY - STD TI - Witters P, Cassiman D, Morava E. Nutritional therapies in congenital disorders of glycosylation (CDG). Nutrients. 2017;9. ID - ref4 ER - TY - JOUR AU - Verheijen, J. AU - Tahata, S. AU - Kozicz, T. AU - Witters, P. AU - Morava, E. PY - 2020 DA - 2020// TI - Therapeutic approaches in congenital disorders of glycosylation (CDG) involving N-linked glycosylation: an update JO - Genet Med VL - 22 UR - https://doi.org/10.1038/s41436-019-0647-2 DO - 10.1038/s41436-019-0647-2 ID - Verheijen2020 ER - TY - JOUR AU - Morelle, W. AU - Potelle, S. AU - Witters, P. AU - Wong, S. AU - Climer, L. AU - Lupashin, V. PY - 2017 DA - 2017// TI - Galactose supplementation in patients With TMEM165-CDG rescues the glycosylation defects JO - J Clin Endocrinol Metab VL - 102 UR - https://doi.org/10.1210/jc.2016-3443 DO - 10.1210/jc.2016-3443 ID - Morelle2017 ER - TY - JOUR AU - Radenkovic, S. AU - Bird, M. J. AU - Emmerzaal, T. L. AU - Wong, S. Y. AU - Felgueira, C. AU - Stiers, K. M. PY - 2019 DA - 2019// TI - The metabolic map into the pathomechanism and treatment of PGM1-CDG JO - Am J Hum Genet VL - 104 UR - https://doi.org/10.1016/j.ajhg.2019.03.003 DO - 10.1016/j.ajhg.2019.03.003 ID - Radenkovic2019 ER - TY - STD TI - Wong SY-W, Gadomski T, van Scherpenzeel M, Honzik T, Hansikova H, Holmefjord KSB, et al. Oral D-galactose supplementation in PGM1-CDG. Genet Med. 2017;19:1226–35. ID - ref8 ER - TY - JOUR AU - Frustaci, A. AU - Chimenti, C. AU - Ricci, R. AU - Natale, L. AU - Russo, M. A. AU - Pieroni, M. PY - 2001 DA - 2001// TI - Improvement in cardiac function in the cardiac variant of Fabry’s disease with galactose-infusion therapy JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJM200107053450104 DO - 10.1056/NEJM200107053450104 ID - Frustaci2001 ER - TY - JOUR AU - Smet, E. AU - Rioux, J. -. P. AU - Ammann, H. AU - Déziel, C. AU - Quérin, S. PY - 2009 DA - 2009// TI - FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy JO - Nephrol Dial Transplant VL - 24 UR - https://doi.org/10.1093/ndt/gfp278 DO - 10.1093/ndt/gfp278 ID - Smet2009 ER - TY - JOUR AU - Scherpenzeel, M. AU - Steenbergen, G. AU - Morava, E. AU - Wevers, R. A. AU - Lefeber, D. J. PY - 2015 DA - 2015// TI - High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation JO - Transl Res VL - 166 ID - Scherpenzeel2015 ER -